Candel Therapeutics, Inc. (CADL) Earnings Per Share (EPS)
Candel Therapeutics, Inc. (CADL) diluted earnings per share by fiscal period. Track EPS in Excel with MarketXLS.
EPS (Earnings Per Share) Data
| Period | Diluted EPS (USD) |
|---|---|
| 2021-12-31 | -$1.91 |
| 2022-12-31 | -$0.65 |
| 2023-12-31 | -$1.31 |
| 2024-12-31 | -$1.74 |
| 2025-12-31 | -$0.72 |
How CADL compares with sector peers
| Symbol | Company | Diluted EPS (latest fiscal year) |
|---|---|---|
| STIM | Neuronetics Inc. | -$0.59 |
| DMAC | DiaMedica Therapeutics Inc. | -$0.70 |
| ARRY | Array Technologies Inc. | -$0.73 |
| EOLS | Evolus Inc. | -$0.80 |
| NEO | NeoGenomics Inc. | -$0.84 |
These are five companies in the same sector as CADL with a comparable annual diluted earnings per share. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Candel Therapeutics, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =EarningsPerShare("CADL")
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | CADL | $12.16 | +3.75% | 2.16M |
| 3 | ||||
| 4 | ||||
| 5 |